1
Oct 26 (Reuters) – Eris Lifesciences Ltd: * SEPT-QUARTER CONSOL NET PROFIT 1.84 BILLION RUPEES * SEPT-QUARTER CONSOL TOTAL REVENUE FROM OPERATIONS 8.92 BILLION RUPEES Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
